Article
Correlation of inhaled long-acting bronchodilators with cardiovascular adverse events in COPD patients: A real-world analysis of post-marketing surveillance data
2023-11-07
Abstract excerpt
<h4>Background: </h4> The question of whether inhaled long-acting bronchodilators (iLABs) increase the incidence of cardiovascular adverse events (CVAEs) remains unresolved. The present study analyzed real world data using the U.S. Food and Drug Administration Adverse Events Reporting System (FAERS) database to evaluate iLABs-related CVAEs in patients with COPD. <h4>Methods:</h4> Disproportionality analysis was us...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 38e694a3-397f-558f-b178-0a5735e03933
- DOI
- 10.22541/au.169934442.22991218/v1
